332 related articles for article (PubMed ID: 28748390)
1. miR-27b-3p, miR-181a-1-3p, and miR-326-5p are involved in the inhibition of macrophage activation in chronic liver injury.
Li W; Chang N; Tian L; Yang J; Ji X; Xie J; Yang L; Li L
J Mol Med (Berl); 2017 Oct; 95(10):1091-1105. PubMed ID: 28748390
[TBL] [Abstract][Full Text] [Related]
2. 15-deoxy-Δ
Li W; Xie J; Yang L; Yang Y; Yang L; Li L
Int Immunopharmacol; 2023 Aug; 121():110491. PubMed ID: 37329807
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Delta12,14-prostaglandin J2.
Ji JD; Kim HJ; Rho YH; Choi SJ; Lee YH; Cheon HJ; Sohn J; Song GG
Rheumatology (Oxford); 2005 Aug; 44(8):983-8. PubMed ID: 15840591
[TBL] [Abstract][Full Text] [Related]
4. 15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) signals through retinoic acid receptor-related orphan receptor-alpha but not peroxisome proliferator-activated receptor-gamma in human vascular endothelial cells: the effect of 15d-PGJ2 on tumor necrosis factor-alpha-induced gene expression.
Migita H; Morser J
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):710-6. PubMed ID: 15662020
[TBL] [Abstract][Full Text] [Related]
5. The peroxisome proliferator-activated receptor gamma (PPARgamma) ligands 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone induce human B lymphocyte and B cell lymphoma apoptosis by PPARgamma-independent mechanisms.
Ray DM; Akbiyik F; Phipps RP
J Immunol; 2006 Oct; 177(8):5068-76. PubMed ID: 17015690
[TBL] [Abstract][Full Text] [Related]
6. 15-Deoxy-Delta12,14-prostaglandin J2 inhibits IL-1beta-induced cyclooxygenase-2 expression in mesangial cells.
Sawano H; Haneda M; Sugimoto T; Inoki K; Koya D; Kikkawa R
Kidney Int; 2002 Jun; 61(6):1957-67. PubMed ID: 12028436
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor gamma is required for the inhibitory effect of ciglitazone but not 15-deoxy-Delta 12,14-prostaglandin J2 on the NFkappaB pathway in human endothelial cells.
Kaplan J; Cook JA; O'Connor M; Zingarelli B
Shock; 2007 Dec; 28(6):722-726. PubMed ID: 17621259
[TBL] [Abstract][Full Text] [Related]
8. Contrasting effects of peroxisome-proliferator-activated receptor (PPAR)gamma agonists on membrane-associated prostaglandin E2 synthase-1 in IL-1beta-stimulated rat chondrocytes: evidence for PPARgamma-independent inhibition by 15-deoxy-Delta12,14prostaglandin J2.
Bianchi A; Moulin D; Sebillaud S; Koufany M; Galteau MM; Netter P; Terlain B; Jouzeau JY
Arthritis Res Ther; 2005; 7(6):R1325-37. PubMed ID: 16277686
[TBL] [Abstract][Full Text] [Related]
9. THE PPARgamma ligand 15d-PGJ2 modulates macrophage activation after injury in a murine trauma model.
Monroy MA; Opperman KK; Pucciarelli M; Yerrum S; Berg DA; Daly JM
Shock; 2007 Aug; 28(2):186-91. PubMed ID: 17510607
[TBL] [Abstract][Full Text] [Related]
10. 15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) and ciglitazone modulate Staphylococcus aureus-dependent astrocyte activation primarily through a PPAR-gamma-independent pathway.
Phulwani NK; Feinstein DL; Gavrilyuk V; Akar C; Kielian T
J Neurochem; 2006 Dec; 99(5):1389-1402. PubMed ID: 17074064
[TBL] [Abstract][Full Text] [Related]
11. 15-deoxy-Delta12,14 prostaglandin J2 up-regulates Kruppel-like factor 4 expression independently of peroxisome proliferator-activated receptor gamma by activating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signal transduction pathway in HT-29 colon cancer cells.
Chen ZY; Tseng CC
Mol Pharmacol; 2005 Nov; 68(5):1203-13. PubMed ID: 16077033
[TBL] [Abstract][Full Text] [Related]
12. 15-deoxy-δ12,14-prostaglandin j2 inhibits osteolytic breast cancer bone metastasis and estrogen deficiency-induced bone loss.
Kim KR; Kim HJ; Lee SK; Ma GT; Park KK; Chung WY
PLoS One; 2015; 10(4):e0122764. PubMed ID: 25859665
[TBL] [Abstract][Full Text] [Related]
13. 15-Deoxy-Δ12,14-prostaglandin J2 induces PPARγ- and p53-independent apoptosis in rabbit synovial cells.
Sakaba Y; Awata H; Morisugi T; Kawakami T; Sakudo A; Tanaka Y
Prostaglandins Other Lipid Mediat; 2014 Jun; 109-111():1-13. PubMed ID: 24680891
[TBL] [Abstract][Full Text] [Related]
14. Diverse cardioprotective signaling mechanisms of peroxisome proliferator-activated receptor-gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone, in reperfusion injury: role of nuclear factor-kappaB, heat shock factor 1, and Akt.
Zingarelli B; Hake PW; Mangeshkar P; O'Connor M; Burroughs TJ; Piraino G; Denenberg A; Wong HR
Shock; 2007 Nov; 28(5):554-63. PubMed ID: 17589386
[TBL] [Abstract][Full Text] [Related]
15. 15-Deoxy-Δ
Chen K; Li JJ; Li SN; Feng J; Liu T; Wang F; Dai WQ; Xia YJ; Lu J; Zhou YQ; Guo CY
Acta Pharmacol Sin; 2017 May; 38(5):672-687. PubMed ID: 28216619
[TBL] [Abstract][Full Text] [Related]
16. 15-deoxy-Δ(12,14) -prostaglandin-J2 and ciglitazone inhibit TNF-α-induced matrix metalloproteinase 13 production via the antagonism of NF-κB activation in human synovial fibroblasts.
Lin TH; Tang CH; Wu K; Fong YC; Yang RS; Fu WM
J Cell Physiol; 2011 Dec; 226(12):3242-50. PubMed ID: 21344384
[TBL] [Abstract][Full Text] [Related]
17. 15d-PGJ2: the anti-inflammatory prostaglandin?
Scher JU; Pillinger MH
Clin Immunol; 2005 Feb; 114(2):100-9. PubMed ID: 15639643
[TBL] [Abstract][Full Text] [Related]
18. 15-Deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) mediates repression of TNF-alpha by decreasing levels of acetylated histone H3 and H4 at its promoter.
Engdahl R; Monroy MA; Daly JM
Biochem Biophys Res Commun; 2007 Jul; 359(1):88-93. PubMed ID: 17532302
[TBL] [Abstract][Full Text] [Related]
19. 15-deoxy-delta12,14-Prostaglandin J2 inhibits tissue factor expression in human macrophages and endothelial cells: evidence for ERK1/2 signaling pathway blockade.
Eligini S; Banfi C; Brambilla M; Camera M; Barbieri SS; Poma F; Tremoli E; Colli S
Thromb Haemost; 2002 Sep; 88(3):524-32. PubMed ID: 12353085
[TBL] [Abstract][Full Text] [Related]
20. 15-Deoxy-Delta(12,14)-prostaglandin J2 induces IL-8 and GM-CSF in a human airway epithelial cell line (NCI-H292).
Chiba T; Ueki S; Ito W; Kato H; Takeda M; Kayaba H; Furue M; Chihara J
Int Arch Allergy Immunol; 2009; 149 Suppl 1():77-82. PubMed ID: 19494510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]